CVS Health Corp
NYSE: CVS
$69.75
+$0.36 (+0.5%)
Closing price April 19, 2024
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including Comcast, CVS, Momo, McCormick, NRG Energy and Sherwin-Williams.
Published:
24/7 Wall St. has put together a preview of some of the most anticipated quarterly reports due this week, including CVS, Roku, Shopify and Walmart.
Published:
Following Monday's President's Day holiday, earnings are on tap to begin again in earnest on Tuesday morning. Here's a look at what analysts expect for three companies in three different sectors.
Published:
U.S. equities posted big gains again last year and that affected profits for short sellers. Still, there were some big winners for short sellers last year.
Published:
Friday's top analyst upgrades and downgrades included Aflac, CME, Chevron, CVS Health, D.R. Horton, Goodyear Tire and Rubber, Lam Research, Micron Technology and U.S. Steel.
Published:
Monday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, American Electric Power, BJ's Wholesale Club, Clorox, HCA Healthcare, Shake Shack, USBancorp, Walt Disney and Xpeng.
Published:
Health care has been a top performer this year, and there is every reason to believe that performance will carry through into 2021. These are four of the highest-ranked health care ideas from the...
Published:
These five well-known stocks from the Raymond James Analysts Current Favorites list are not overextended and overbought, and they look like very good ideas for growth investors looking to reset...
Published:
CVS reported better than expected quarterly results before the opening bell on Friday and named its incoming chief executive.
Published:
Here are six health care stocks that appear to be specific winners based on a mixed Congress, regardless of which presidential candidate is declared the winner.
Published:
24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including General Motors, T-Mobile and Uber.
Published:
Thursday's top analyst upgrades and downgrades included Boston Scientific, CVS Health, FMC, Lennar, NovoCure, Penn National Gaming, Ruth's Hospitality, Stitch Fix and Veeco Instruments.
Published:
Pharmacy and health insurer CVS handily beat expected earnings and revenue estimates for the second quarter.
Published:
This is a preview of a few of the most anticipated quarterly reports due this week, including CVS Health, Uber and Walt Disney.
Published:
See why UBS feels these 10 stocks in a variety of sectors with solid upside potential could do very well with a Trump victory in November.
Published: